Authors:
Bayley, JP
de Rooij, H
van den Elsen, PJ
Huizinga, TWJ
Verweij, CL
Citation: Jp. Bayley et al., Functional analysis of linker-scan mutants spanning the-376-308,-244, and-238 polymorphic sites of the TNF-alpha promoter, CYTOKINE, 14(6), 2001, pp. 316-323
Authors:
van der Linden, MW
Westendorp, RGJ
Zidane, M
Meheus, L
Huizinga, TWJ
Citation: Mw. Van Der Linden et al., Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens, J RHEUMATOL, 28(2), 2001, pp. 284-287
Citation: Ja. Bruijn et al., Classifying lupus nephritis: A 32-year-old woman with systemic lupus erythematosus and nephritic syndrome, AM J KIDNEY, 37(3), 2001, pp. 653-657
Authors:
van der Pol, WL
Huizinga, TWJ
Vidarsson, G
van der Linden, MW
Jansen, MD
Keijsers, V
de Straat, FGJLV
Westerdaal, NAC
de Winkel, JGJV
Westendorp, RGJ
Citation: Wl. Van Der Pol et al., Relevance of Fc gamma receptor and interleukin-10 polymorphisms for meningococcal disease, J INFEC DIS, 184(12), 2001, pp. 1548-1555
Authors:
Gibson, AW
Edberg, JC
Wu, JM
Westendorp, RGJ
Huizinga, TWJ
Kimberly, RP
Citation: Aw. Gibson et al., Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus, J IMMUNOL, 166(6), 2001, pp. 3915-3922
Authors:
van Ede, AE
Laan, RFJM
Rood, MJ
Huizinga, TWJ
van de Laar, MAFJ
van Denderen, CJ
Westgeest, TAA
Romme, TC
de Rooij, DJRAM
Jacobs, MJM
de Boo, TM
van der Wilt, GJ
Severens, JL
Hartman, M
Krabbe, PFM
Dijkmans, BAC
Breedveld, FC
van de Putte, LBA
Citation: Ae. Van Ede et al., Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis - A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study, ARTH RHEUM, 44(7), 2001, pp. 1515-1524
Authors:
Goossens, PH
Havenga, MJE
Pieterman, E
Lemckert, AA
Breedveld, FC
Bout, A
Huizinga, TWJ
Citation: Ph. Goossens et al., Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber, ARTH RHEUM, 44(3), 2001, pp. 570-577
Authors:
van Ede, AE
Laan, RFJM
Blom, HJ
Huizinga, TWJ
Haagsma, CJ
Giesendorf, BAJ
de Boo, TM
van de Putte, LBA
Citation: Ae. Van Ede et al., The C677T mutation in the methylenetetrahydrofolate reductase gene - A genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients, ARTH RHEUM, 44(11), 2001, pp. 2525-2530
Authors:
Goossens, PH
Vogels, R
Pieterman, E
Havenga, MJE
Bout, A
Breedveld, FC
Valerio, D
Huizinga, TWJ
Citation: Ph. Goossens et al., The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue, ARTH RHEUM, 44(1), 2001, pp. 48-52
Authors:
van der Linden, MW
van Lopik, T
Aarden, LA
Westendorp, RGJ
Huizinga, TWJ
Citation: Mw. Van Der Linden et al., Soluble CD95 concentrations are increased in patients with severe systemiclupus erythematosus, but not in their first degree relatives, ANN RHEUM D, 60(3), 2001, pp. 237-241
Authors:
Rood, MJ
Haverman, JF
van Duinen, SG
Breedveld, FC
Verschuuren, JJGM
Huizinga, TWJ
Citation: Mj. Rood et al., CNS involvement in systemic lupus erythematosus: a case with remarkable histopathological findings, ANN RHEUM D, 60(3), 2001, pp. 299-300
Authors:
Polderman, MCA
Huizinga, TWJ
Le Cessie, S
Pavel, S
Citation: Mca. Polderman et al., UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial, ANN RHEUM D, 60(2), 2001, pp. 112-115
Citation: Rgj. Westendorp et Twj. Huizinga, Molecular analysis of gene-polymorphisms affecting the host response to infection, METH MOL M, 67, 2001, pp. 499-512
Authors:
Goossens, PH
Heemskerk, B
van Tongeren, J
Zwinderman, AH
Vlieland, TPMV
Huizinga, TWJ
Citation: Ph. Goossens et al., Reliability and sensitivity to change of various measures of hand functionin relation to treatment of synovitis of the metacarpophalangeal joint in rheumatoid arthritis, RHEUMATOLOG, 39(8), 2000, pp. 909-913
Authors:
Huizinga, TWJ
Keijsers, V
Yanni, G
Hall, M
Ramage, W
Lanchbury, J
Pitzalis, C
Drossaers-Bakker, WK
Westendorp, RGJ
Breedveld, FC
Panayi, G
Verweij, CL
Citation: Twj. Huizinga et al., Are differences in interleukin 10 production associated with joint damage?, RHEUMATOLOG, 39(11), 2000, pp. 1180-1188
Authors:
van der Linden, MW
Westendorp, RGJ
Sturk, A
Bergman, W
Huizinga, TWJ
Citation: Mw. Van Der Linden et al., High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus, J INVES MED, 48(5), 2000, pp. 327-334
Citation: Dt. Huinink et al., Diabetes insipidus in metastatic cancer: Two case reports with review of the literature, ANN ONCOL, 11(7), 2000, pp. 891-895
Authors:
de Jong, BA
Schrijver, HM
Huizinga, TWJ
Bollen, ELEM
Polman, CH
Uitdehaag, BMJ
Kersbergen, MC
Sturk, A
Westendorp, RGJ
Citation: Ba. De Jong et al., Innate production of interleukin-10 and tumor necrosis factor affects the risk of multiple sclerosis, ANN NEUROL, 48(4), 2000, pp. 641-646
Citation: Mj. Rood et al., Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy, J RHEUMATOL, 27(8), 2000, pp. 2057-2059